Rufinamide Oral Suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients aged 1 year old and older, and in adults.
Toprail Pharmaceuticals won for its Gluco-To-Go oral glucose gels, and Intuity Medical was a finalist for its POGO Automatic Blood Glucose Monitoring System.